Drug Trial Radar · NCT05593575
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Last checked: Nov 19, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
305
Actual
Start
Mar 22, 2023
Primary completion
Dec 31, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Oct 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To preliminarily evaluate the efficacy and safety of the renin inhibitor (SPH3127 tablets) in reduction in proteinuria in patients with diabetic kidney disease with valsartan as the comparator, and determine the recommended dose.
Conditions
- Diabetic Kidney Disease
Interventions
SPH3127+SPH3127matching placebo+valsartan matching placeboDrug
1 tablet of SPH3127 (50 mg) ,3 tablets of SPH3127 (50mg)matching placebo, 1 capsule of valsartan matching placebo, orally, once daily for 12 consecutive weeks
SPH3127+SPH3127matching placebo+valsartan matching placeboDrug
2 tablet of SPH3127 (50 mg) ,2 tablets of SPH3127 (50mg)matching placebo, 1 capsule of valsartan matching placebo, orally, once daily for 12 consecutive weeks
SPH3127+valsartan matching placeboDrug
4 tablet of SPH3127 (50 mg) , 1 capsule of valsartan matching placebo, orally, once daily for 12 consecutive weeks
SPH3127 matching placebo+valsartanDrug
4 tablets of SPH3127 (50mg)matching placebo, 1 capsule of valsartan, orally, once daily for 12 consecutive weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in UACRTime frame: at the end of Week 12 of treatment
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tsinghua Changgeng Hospital
Beijin, China
Beijing Anzhen Hospital,Capital Medical University
Beijing, China
Beijing Tiantan Hospital,Capital Medical University
Beijing, China
Beijing Tongren Hospital
Beijing, China
Peking Union Medical College Hospital
Beijing, China
Xiangya Hospital Central South University
Changsha, China
Chengdu Seventh People's Hospital
Chengdu, China
Sichuan Provincial People's Hospital
Chengdu, China
West China Hospital of Sichuan University
Chengdu, China
Shunde Hospital of Southern Medical University
Foshan, China
The Second Affiliated Hospital of Hainan Medical University
Haikou, China
Huizhou First Hospital
Huizhou, China
Qilu Hospital of Shandong University
Jinan, China
The First Affiliated Hospital of Shandong First Medical University
Jinan, China
Ningbo No.2 Hospital
Ningbo, China
Affiliated Zhongshan Hospital of Fudan University,Qingpu Branch
Shanghai, China
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, China
Shanghai Fengxian District Central Hospital
Shanghai, China
Shanghai Minhang District Central Hospital
Shanghai, China
Sheng Jing Hospital of China Medical University
Shenyang, China
The First Affiliated Hospital of China Medical University
Shenyang, China
The Seventh Affiliated Hospital,Sun Yat-sen University
Shenzhen, China
Second Hospital of Shanxi Medical University
Taiyuan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
The 900 Hospital of the Joint Service Support Force of the People's Liberation Army of China
Fuzhou, Fujian, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
The First Affiliated Hospital,Sun Yat sen University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China
Harbin Medical University Affiliated Fourth Hospital
Harbin, Heilongjiang, China
Luoyang Third People's Hospital
Luoyang, Henan, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
The Third Hospital of Wuhan
Wuhan, Hubei, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The Second Norman Bethune Hospital of Jilin University
Changchun, Jilin, China
The First People's Hospital of Yinchuan
Yinchuan, Ningxia, China
Qinghai University Affiliated Hospital
Xining, Qinghai, China
Xi'an Daxing Hospital
Xi’an, Shanxi, China
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.